Medpace Reports Q3 2026 Revenue of $716.0 Million, Updates 2026 Outlook
Medpace reported Q3 2026 EPS of $4.84 and revenue of $716.0 million, exceeding FactSet estimates of $4.44 and $714.5 million, respectively. It now expects full-year 2026 revenue of $2.84 billion to $2.86 billion and EPS of $17.97 to $18.32.
Medpace Holdings, Inc. posted third-quarter 2026 revenue of $716.0 million, above the FactSet estimate of $714.5 million. Earnings per share (EPS) came in at $4.84, topping the consensus estimate of $4.44. The company revised its full-year 2026 outlook, projecting revenue of $2.84 billion to $2.86 billion and EPS of $17.97 to $18.32.
Both ranges are favorable compared with prior market expectations.